Objective: To explore the inhibitory effect of targeting miRNA on the expression of vascular endothelial growth factor (VEGF) and cell proliferation in malignant melanoma (MM) SKmel-28 cells.
Methods: Recombination miRNA plasmid vectors targeting VEGF gene were transfected into SKmel-28 cells via Lipofectamine 2000. The integrity of the inserted fragments was detected using colony PCR and sequence analysis. The expression of VEGF mRNA and protein in SKmel-28 cells was detected by RT-PCR and Western blotting, respectively. MTS assay was used to determine the inhibitory effect of a selected targeting miRNA on SKmel-28 cell proliferation, and the apoptosis of SKmel-28 cells was detected using flow cytometry.
Results: Transfection with the targeting miRNAs significantly down-regulated the expressions of VEGF mRNA and protein in SKmel-28 cells (P<0.01), and the miRNA construct X-26-2n-1 showed the highest inhibitory effect. The miRNA X-26-2n-1 significantly suppressed SKmel-28 cell proliferation in a time-dependent manner (P<0.01) and increased the early, late and overall apoptosis rates of the cells (P<0.01).
Conclusion: The targeting miRNA we constructed can effectively suppress the cell proliferation and induce apoptosis of SKmel-28 cells by down-regulating the expressions of VEGF gene.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Toxicity and Dermatokinetic Analysis of Ibrutinib in Human Skin Models.
Pharmaceutics
October 2024
Interdisciplinary Biosciences Laboratory, Faculty of Medicine, University of Brasilia, Brasília 70910-900, DF, Brazil.
Ibrutinib (IBR) is a tyrosine kinase inhibitor under investigation in preclinical and clinical settings as an alternative treatment for melanoma. Nevertheless, the limited oral bioavailability of IBR and the need for high doses of the drug to kill melanoma cells are major drawbacks for this purpose. Considering that melanoma is restricted to the skin at early stages, the topical application of IBR might constitute an effective and safer administration route.
View Article and Find Full Text PDFOptimization of Phenolic Compounds Extraction from Aerial Parts of S. C. Arroyo by Ultrasound- and Microwave-Assisted Extraction.
Molecules
July 2024
Instituto de Bioprospección y Fisiología Vegetal (INBIOFIV-CONICET-UNT), San Martín 1545, San Miguel de Tucumán 4000, Tucumán, Argentina.
S. C. Arroyo is a subshrub or shrub that is indigenous to the arid and semiarid region of northern Argentina and is known to possess several medicinal properties.
View Article and Find Full Text PDFA Proteomics Approach Identifies RREB1 as a Crucial Molecular Target of Imidazo-Pyrazole Treatment in SKMEL-28 Melanoma Cells.
Int J Mol Sci
June 2024
IRCCS Ospedale Policlinico San Martino, Proteomics and Mass Spectrometry Unit, L.go. R. Benzi, 10, 16132 Genova, Italy.
Cutaneous melanoma is the most dangerous and deadly form of human skin malignancy. Despite its rarity, it accounts for a staggering 80% of deaths attributed to cutaneous cancers overall. Moreover, its final stages often exhibit resistance to drug treatments, resulting in unfavorable outcomes.
View Article and Find Full Text PDFAnticancer Effects of the Novel Pyrazolyl-Urea GeGe-3.
Int J Mol Sci
May 2024
Centre for Research in Biosciences, School of Applied Sciences, University of the West of England, Coldharbour Lane, Frenchay, Bristol BS16 1QY, UK.
In a screen of over 200 novel pyrazole compounds, ethyl 1-(2-hydroxypentyl)-5-(3-(3-(trifluoromethyl) phenyl)ureido)-1-pyrazole-4-carboxylate (named GeGe-3) has emerged as a potential anticancer compound. GeGe-3 displays potent anti-angiogenic properties through the presumptive targeting of the protein kinase DMPK1 and the Ca2-binding protein calreticulin. We further explored the anticancer potential of GeGe-3 on a range of established cancer cell lines, including PC3 (prostate adenocarcinoma), SKMEL-28 (cutaneous melanoma), SKOV-3 (ovarian adenocarcinoma), Hep-G2 (hepatocellular carcinoma), MDA-MB231, SKBR3, MCF7 (breast adenocarcinoma), A549 (lung carcinoma), and HeLa (cervix epithelioid carcinoma).
View Article and Find Full Text PDFMultifaceted approach toward mapping out the anticancer properties of small molecules via in vitro evaluation on melanoma and nonmelanoma skin cancer cells, and in silico target fishing.
Chem Biol Drug Des
January 2024
School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana - Monroe, Monroe, Louisiana, USA.
Article Synopsis
- Melanoma and nonmelanoma skin cancers are leading forms of skin cancer, prompting research for new anticancer compounds through in vitro assays and in-silico methods.
- Screening of a small library of previously prepared compounds revealed 35 that inhibited the growth of skin cancer cell lines, particularly showing strong effects on A431 and SCC-12 cells.
- The most effective compounds (11 and 13) induced apoptosis and disrupted cancer-promoting pathways, suggesting potential targets for further study and development in treating skin cancers.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!